Find similar content

Source channel @githubtrending · Post #15033 · Aug 6

#shell#buildroot_external_tree#firmware#ingenic#ip_camera#ipc#ipcamera Thingino is free, open-source firmware designed specifically for IP cameras using Ingenic SoC chips. It customizes the software to fit each supported camera model, making the camera easier to use and more efficient. You can build the firmware yourself using the provided instructions and tools, and there is a helpful web interface to control camera features like pan, tilt, night mode, and streaming. This gives you more control and flexibility over your camera without relying on proprietary software. It supports many camera models, and the community offers resources like a wiki, chat groups, and development guides to help you get started and customize your device. This benefits you by providing a customizable, transparent, and community-supported alternative to closed camera firmware. https://github.com/themactep/thingino-firmware

Hashtags

#shell #buildroot_external_tree #firmware #ingenic #ip_camera #ipc #ipcamera

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment